Figure 5

Comparisons of GTMM predictions with measured human data of (A) tracer blood lead for a male absorbing 17.5 μg/day lead-204 for 104 days (Rabinowitz et al., 1976 [46]), and (B) blood lead for a subgroup of children from the Cincinnati Prospective Lead Study (Bornschein et al., 1985 [49]), using the O'Flaherty lead exposure model to characterize ingestion and inhalation intakes [48]. The Cincinnati data represent the median blood lead measurements of individuals monitored from birth to early childhood, and only include children whose highest blood lead concentration did not exceed 15 μg/dL.